What kind of expertise do you need?


ExpertsIn business, people fuel success
Zac Stillerman
Zac Stillerman
President and General Manager
Committed to ensuring that patients get the right medicine at the right time so they can thrive—and guiding clients as they rise to this challenge. Deep understanding of the US healthcare provider market developed through decades of experience, including expertise in core system optimization, clinical operations, value-based care, physician practice management, financial reporting, and revenue cycle.
J. Bruce Leavitt
J. Bruce Leavitt, MBA
Executive Vice President, Managing Partner
Innovator of novel promotional effectiveness measures, insight-driven analysis methodologies, and dynamic CRM-based tools and applications for account management and pull-through. Expert in solving market access challenges for pharma across market channels, therapeutic classes, and routes of administration.
Ross Maclean
Ross Maclean, MD, PHD, MBA.
Executive Vice President, General Manager
Dr. Maclean has more than 20 years of progressive experience in health services and outcomes research, health economics, health system design, health policy, and market access. With 12 years spent in the biopharmaceutical industry, he gained wide exposure to the R&D environment as a leader of the global Health Economics and Outcomes Research (HEOR) function for cardiovascular, metabolics, and immunology products at Bristol-Myers Squibb.
Larry Blandford
Larry Blandford, PharmD
Executive Vice President, Managing Partner
Industry leader in market insights, medication management, and access strategy for pharmaceuticals. Combines deep payer experience and insights across the market access landscape to drive strategic planning and guide execution.
Kathy Lang
Kathy Lang, PhD
Vice President
Long-standing HEOR leader, advising clients in the life sciences industry on real-world evidence strategy and execution studies. Expert in statistical/econometric methods and leveraging primary and secondary data. Authority across a wide array of therapeutic areas and study designs, including clinical trials, model-based cost-effectiveness and budget impact analyses, trial-based economic evaluations, retrospective database studies, meta-analyses, enriched retrospective and observational studies, and software tool development for field-based teams. Widely published in peer-review journals on a range HEOR topics.
Ashwin Athri
Ashwin Athri, MBA
Senior Vice President
Technology innovator, charged with advancing data analytics through the development and implementation of novel technology solutions. Specialized knowledge of prescriber targeting, opportunity analysis, database design and development, payer value proposition creation, pricing, and Rx-to-over-the-counter (OTC) forecast models.
Maria Lorenzi
Maria Lorenzi
Director
Respected biostatistician, widely published author and leading expert in literature reviews and network meta-analyses, including complex and non-standard Bayesian network meta-analyses. Strategic focus on oncology, diabetes, rheumatology and immunology. Extends insights through custom-developed code (R functions and packages) to improve data preparation and synthesis of raw results for presentation.
Alexander Grosvenor
Alexander Grosvenor
Senior Vice President
Wide-ranging expert in global pricing and market access, with specific knowledge of European markets and the disciplines of launch sequencing, cross-indication pricing, international price referencing, and global launch pricing. Specialized focus in orphan indications and cell and gene therapies, backed by extensive knowledge of oncology, cardiovascular disease, central nervous system diseases, human immunodeficiency virus, and multiple sclerosis.
Aaron Salamon
Aaron Salamon, MBA
Senior Director
Expert in payer and commercial analytics with a unique ability to bridge disparate payer data to derive actionable insights. Deep understanding of the structures and functions of managed markets organizations across the pharmaceutical industry. Straddles the cutting edge of technological and environmental changes in healthcare.
Shannon Cope
Shannon Cope, MSc
Director
Seasoned research scientist specializing in evidence strategy and decision modeling, leading teams that are focused on oncology, cardiovascular diseases, respiratory diseases, diabetic macular edema, Crohn’s and ulcerative colitis and epilepsy. Widely published author of papers in peer-reviewed journals on both sides of the Atlantic.
Craig White
Craig White, PhD
Vice President, Managing Director
Industry-leading strategic expert with focus on precommercial strategy, commercial strategy, launch strategy, salesforce targeting, alignment and messaging. Specialist in value-based pricing, outcomes-based contracting and use of real-world data and analytics, bolstered by a unique blend of business and technology expertise. Has developed and commercialized multiple large-scale US healthcare datasets.
Marie Davenport
Marie Davenport
Director
Expert in data integration and key drivers impacting pharmaceutical product uptake. Leader of managed markets initiatives, from requirements gathering, data structure design and development, test case creation and execution, and ongoing updates, modifications, and delivery of monthly refreshes. Develops custom analytic tools to meet specific client needs.
Naomi Sacks
Naomi Sacks, PhD
Director
Health policy expert and leading researcher into real-world evidence, delivering scientifically rigorous and commercially relevant research to global biopharmaceutical companies. Specialized knowledge of acute myocardial infarction hospitalizations and outcomes, as well as diabetes, osteoarthritis and broader heart disease issues. Academician, peer reviewer for seven respected journals, and frequent contributor to leading medical journals.
David Kaplan
David Kaplan, RPh
Senior Vice President
Results-driven pharmaceutical marketer and market research leader, with a history of developing and executing innovative approaches to the understanding of global and US payer customers and healthcare systems, developing value-based pricing across dozens of brands. Thought leader in business analysis, pricing and contracting, modeling and strategy development.
Eric Daugherty
Eric Daugherty, MBA
Senior Vice President
Long-standing leader in biopharmaceutical access and managed markets strategies, with expertise spanning strategic pricing and health outcomes, pull-through messaging, salesforce performance reports, business-to-business brand management, disease management, and account management. Specialized insight into the specifics of mental health provider networks.
Greg Berzolla
Greg Berzolla, MBA
Senior Vice President
Payer industry veteran specializing in pharmacy benefits management, organizational design, and operational improvement projects spanning claims processing, customer service, membership accounting, and clinical services. Expert in Medicare Star ratings measurement and improvement for prescription drug plans and Medicare Advantage plans, spanning clinical and operational areas.
Harry Grant Schiavi
Harry Grant Schiavi
Managing Partner
Industry expert and advisor with 28+ years of experience in the pharmaceutical and biotechnology industry, with particular emphasis on market access, pricing and reimbursement. Specialized focus on evaluating and quantifying market access risks associated with both innovative and undifferentiated products as well as the intricacies and complexities of market access contracting and negotiation.
Ivar Jensen
Ivar Jensen, MBA
Director
Veteran health economist focused on developing rigorous and commercially relevant BIMs, cost calculators, and other health economic models for life sciences companies. Expert in the development of health economic models, HEOR value messages, commercial assessments, merger and acquisition support, asset valuation, and competitive analysis across many therapeutic areas.
Jay Jauregui
Jay Jauregui
Senior Vice President, Managing Director
Accomplished management consultant with an emphasis in biotechnology, pharmaceuticals, medical devices, and consumer products. 150+ biotech and pharmaceutical engagements, including the development of market access and reimbursement strategies, payer value propositions, and pricing and contracting analyses, as well as specialty distribution strategies for small molecules, biologics, and orphan products. Expertise in a wide range of therapeutic areas and drug classes, including specialty, orphan, oncology, and traditional products.
Jeroen Jansen
Jeroen Jansen, PhD, MSc
Vice President, Chief Scientist
Recognized expert in evidence synthesis and decision modeling for value assessment of medical interventions. Adjunct Professor of Health Research & Policy (Epidemiology) at Stanford University, co-author of a textbook on network meta-analysis, and widely published on applied and methods research in his areas of expertise. Lead Scientific Advisor of the Open Source Value Project (OSVP) at the Innovation and Value Initiative (IVI).
Mridul Malhotra
Mridul Malhotra, MPH
Senior Vice President, Managing Director
Operational and strategic expert trusted by prescribers, hospitals administrators, and pharmaceutical and biotech executives. Developer of key global pricing and market access strategies that articulate clinical evidence to substantiate value for top biopharma and medical device products. Expertise spans all aspects of strategic business planning, including burden of disease and landscape assessments, global value propositions and value stories, revenue forecasting, licensing assessments, cost-effectiveness/budget impact modeling, and dossier development.
Phil Cyr
Phil Cyr, MPH
Vice President
HEOR industry veteran with experience spanning health economics and health policy research, health technology assessment and payer experience, and a strong record of conducting published, peer-reviewed research. Leader in the development and execution of academically rigorous and commercially relevant HEOR studies. Peer reviewer for the American Journal of Managed Care.
Sam Keeping
Sam Keeping
Director
Experienced health economist who specializes in integrating comparative effectiveness results into economic models. Has helped produce submissions to regulatory and health technology assessment agencies across the globe in a range of therapeutic areas, including oncology, ophthalmology, neurology, and infectious disease.
Steve Carter
Steve Carter
Senior Vice President
Industry expert focused on pricing and market access, opportunity valuation, product launch, channel strategy, customer segmentation, contracting, and competitive gaming. Sought-after author of articles and industry briefs, and presenter at international conferences on topics ranging from payer value proposition and pricing to the impact of healthcare reform.
Brett DiNatale
Brett DiNatale, PhD
Director
Seasoned veteran with over 15 years of experience analyzing healthcare data to quantify and model market dynamics. Focused on utilizing the diverse range of data available to address clients' business questions and to optimize their strategies. Expertise with market access and longitudinal patient data sources, advanced methodologies including predictive modeling and machine learning, and systems and solution architecture and deployment.
Jason Shafrin
Jason Shafrin, PhD
Senior Director
Dr. Shafrin is an expert in value-based purchasing methods, quality of care measures, discrete choice experiment survey design, health insurance claims data analysis, and digital medicine. Dr. Shafrin has not only developed reports to advise government agencies such as the Institute of Medicine and Centers for Medicare and Medicaid Services (CMS), but his research has also been published in leading journals of economics, medicine, and health policy, including the Journal of the American Medical Association, Health Affairs, Health Economics, and Health Services Research. Prior to joining PHE, Dr. Shafrin served as a policy lead for Acumen, LLC. In this role, Dr. Shafrin helped CMS implement a number of provisions of the Affordable Care Act, including the design of value-based purchasing programs for hospitals, physicians, and home health agencies. Dr. Shafrin is also the Director of Research at the Innovation and Value Initiative.
Contact us
Discover exactly what Precision can do for you. We look forward to learning about your needs, exploring how we can support you, and sharing our proven approaches. For information and inquiries, please contact:
Zac Stillerman
Zac Stillerman
President and General Manager
phone-icon +1 240.316.3451
Larry Blandford
Larry Blandford, PharmD
Executive Vice President and Managing Partner
phone-icon +1 212.686.2650
J. Bruce Leavitt
J. Bruce Leavitt, MBA
Executive Vice President and Managing Partner
phone-icon +1 203.487.5240
Ross Maclean
Ross Maclean, MD, PHD, MBA
Executive Vice President, General Manager
phone-icon +1 310.984.7708
Harry Grant Schiavi
Harry Grant Schiavi
Managing Partner
phone-icon +1 302.379.1702
arrow-top